Clinical Trials
63 trialsPeds IMPACT
University of Florida
NOVA-GBM
Myosin Therapeutics Inc.
PIRe
Rigshospitalet, Denmark
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
Washington University School of Medicine
Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
M.D. Anderson Cancer Center
EViDENCE-BT
University of Zurich
MELODY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
NRG Oncology
BRiTE
Duke University
STARGATE
University Hospital, Essen
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
University of Iowa
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
NF118
University of Alabama at Birmingham
Oral Gallium Maltolate for Recurrent Glioblastoma
Medical College of Wisconsin
A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression
Starlight Therapeutics Inc.
HipoGBM
Hospital do Coracao
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Vanderbilt-Ingram Cancer Center
A Study for Cerebral Open Flow Microperfusion
Mayo Clinic
Andro-iGlio
Assistance Publique - Hôpitaux de Paris
A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
PRC
The Cooper Health System
Bvax
Northwestern University
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Jonsson Comprehensive Cancer Center
Phase I Trial of pH Resections of GBM at VA
VA Office of Research and Development
Imaging Acetadote Metabolism in Glioblastoma
University of Texas Southwestern Medical Center
Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
University of California, San Francisco
Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency
University of Cincinnati
Limited Target Volume Radiotherapy After Glioblastoma Surgery
Jiangxi Provincial Cancer Hospital
BrainUS-AI
Hospital del Rio Hortega
OPTICAL
CRISM Therapeutics LTD
Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma
ZSky Biotech Inc
Cerebraca-02/3
Everfront Biotech Co., Ltd.
ReVoGlio
University of Zurich
EARLYBRAINPET
Beta Emitting Accurate Monitored Systems
Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
GLIOMIT
Centre Hospitalier Universitaire, Amiens
NG101m Adjuvant Therapy in Glioblastoma Patients
NeuGATE Theranostics
GLADIATOR
Tata Memorial Centre
Phase 2 Clinical Trial of KH617
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
Case Comprehensive Cancer Center
PIONEER
Erasmus Medical Center
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma
Tongji Hospital
ORGA-GLIO
Centre Henri Becquerel
GLIODIS
Olympion Medical Center
SUGRI
Rigshospitalet, Denmark
Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
First Affiliated Hospital, Sun Yat-Sen University
Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
University of Sao Paulo General Hospital
GlioPDO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
Huashan Hospital